Cargando…
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
Chronological age represents the greatest risk factor for many life-threatening diseases, including neurodegeneration, cancer, and cardiovascular disease; ageing also increases susceptibility to infectious disease. Current efforts to tackle individual diseases may have little impact on the overall h...
Autores principales: | Walters, Hannah E., Cox, Lynne S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121351/ https://www.ncbi.nlm.nih.gov/pubmed/30096787 http://dx.doi.org/10.3390/ijms19082325 |
Ejemplares similares
-
mTORC1 and mTORC2 in cancer and the tumor microenvironment
por: Kim, Laura C., et al.
Publicado: (2016) -
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
por: Feldman, Morris E, et al.
Publicado: (2009) -
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary Hypertension
por: Tang, Haiyang, et al.
Publicado: (2018) -
mTORC1 Crosstalk With Stress Granules in Aging and Age-Related Diseases
por: Cadena Sandoval, Marti, et al.
Publicado: (2021) -
Both mTORC1 and mTORC2 are involved in the regulation of cell adhesion
por: Chen, Long, et al.
Publicado: (2015)